Stockscreener 앱 받기
259.79
7.02%
-19.62
전일 마감가:
$279.41
열려 있는:
$279.26
하루 거래량:
1.50M
Relative Volume:
2.11
시가총액:
$18.69B
수익:
$2.96B
순이익/손실:
$487.70M
주가수익비율:
38.92
EPS:
6.6758
순현금흐름:
$344.00M
1주 성능:
-5.71%
1개월 성능:
-2.50%
6개월 성능:
+15.78%
1년 성능:
-22.96%
1일 변동 폭
$259.39
$279.39
1주일 범위
$259.39
$281.55
52주 변동 폭
$187.43
$348.90
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
259.79 | 20.10B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Aug Breakouts: Is West Pharmaceutical Services Inc stock showing strong momentumJuly 2025 Outlook & Verified Chart Pattern Trade Signals - baoquankhu1.vn
West Pharmaceutical Services Inc (WST) Stock Price Down 4.85% on Jan 16 - GuruFocus
West Pharmaceutical Services, Inc. $WST Shares Sold by EULAV Asset Management - MarketBeat
Earnings Preview: What to Expect From West Pharmaceutical Services' Report - inkl
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Finviz
Gov. Braun accelerates life sciences leadership with more than 1,300 new high wage jobs across the state - WBIW
Is It Time To Reassess West Pharmaceutical Services (WST) After Its Recent Share Price Slide - Yahoo Finance
AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services - Med Device Online
Wall Street Analysts See a 26.42% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High? - sharewise.com
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines - Benzinga
AbbVie adds Arizona plant to $10bn US manufacturing push - The Pharma Letter
Chicago's AbbVie to acquire Tempe medical device manufacturing facility - The Business Journals
Key facts: AbbVie partners with RemeGen; acquires West Pharma rights - TradingView — Track All Markets
Strategy To YieldBoost West Pharmaceutical Services From 0.3% To 5.2% Using Options - Nasdaq
AbbVie Inc. (NYSE : ABBV) entered into a definitive agreement to acquire Device manufacturing facility in Tempe, Arizona from West Pharmaceutical Services, Inc. (NYSE - marketscreener.com
West Pharmaceutical Selling SmartDose 3.5mL On-Body Delivery System Manufacturing Rights To AbbVie For $112.5 Million - Pulse 2.0
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines - Sahm
West Pharmaceutical Services To Sell SmartDose Assets To AbbVie - citybiz
AbbVie to acquire West Pharmaceutical’s Arizona facility for $175 million By Investing.com - Investing.com Canada
AbbVie to acquire West Pharmaceutical’s Arizona device manufacturing facility - Indian Pharma Post
AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma - marketscreener.com
West Pharmaceutical (WST) to Sell SmartDose System Rights to Abb - GuruFocus
West Pharmaceutical (WST) Sells Arizona Facility to AbbVie for E - GuruFocus
AbbVie to buy Arizona manufacturing facility from West Pharmaceutical (WST:NYSE) - Seeking Alpha
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie - Chartmill
West Pharmaceutical Services, Inc. $WST Shares Sold by Parnassus Investments LLC - MarketBeat
West Pharmaceutical Services and Philadelphia Eagles Partner for Earth Day Initiative - MSN
Is West Pharmaceutical Services Inc. stock dividend yield sustainablePortfolio Performance Summary & Accurate Intraday Trading Signals - Улправда
SG Americas Securities LLC Increases Stock Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Moves - Yahoo Finance
Why The Narrative Around West Pharmaceutical Services (WST) Is Shifting On 2026 Outlook And Valuation - Yahoo Finance
Will West Pharmaceutical Services Inc. stock attract ESG investorsJuly 2025 Closing Moves & Free Fast Gain Swing Trade Alerts - ulpravda.ru
Pharmaceutical company planning to employ 300 workers in Greenfield - Inside INdiana Business
Is West Pharmaceutical Services Inc. stock trading at attractive multiplesJuly 2025 Spike Watch & Smart Investment Allocation Insights - ulpravda.ru
Why West Pharmaceutical Services Inc. stock is a value investor pickWeekly Profit Recap & Scalable Portfolio Growth Ideas - ulpravda.ru
Will West Pharmaceutical Services Inc. stock benefit from infrastructure spendingDollar Strength & Risk Managed Investment Entry Signals - Улправда
West Pharmaceutical Services, Inc. $WST Shares Purchased by Birch Hill Investment Advisors LLC - MarketBeat
KeyBanc Sees Injectable GLP-1s Driving Ongoing Demand for WST - Finviz
A Look At West Pharmaceutical Services (WST) Valuation As Margins Weaken And Growth Trails Healthcare Peers - Sahm
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
Analysts Offer Insights on Healthcare Companies: Agilent (A) and Tenet Healthcare (THC) - The Globe and Mail
14 Best Dividend Growth Stocks to Buy and Hold in 2026 - Insider Monkey
2026 world cup star players tips: Is West Pharmaceutical Services Inc. stock dividend yield sustainable2026 world cup usa national team round of 32 playmakers low block defense group prediction guide - Улправда
Asset Management One Co. Ltd. Buys 10,009 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc Stock Price Live, Charts & News - The Economic Times
West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 25% Upside Potential - DirectorsTalk Interviews
Who Owns West Pharmaceutical Services? Top Shareholders and Recent Insider Trades - TIKR.com
Investing in West Pharmaceutical Services (NYSE:WST) three years ago would have delivered you a 20% gain - simplywall.st
West Pharmaceutical Services, Inc. $WST Shares Acquired by North Growth Management Ltd. - MarketBeat
Biotech’s New Edge: 5 Companies Mastering "How" We Dose - The Globe and Mail
Ethic Inc. Purchases 4,206 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
0.07%
자본화:
|
볼륨(24시간):